neoSurgical is a commercial-stage company with FDA approval for neoClose®, designed to be the standard for laparoscopic surgery port site closure.
Stage
$500K in TTM Revenue
Location
Atlanta, GA, US
Currency
USD
Incorporation Type
LLC
Company Summary
The standard for port site closure has been Closed Loop Suture. neoClose® is a superior alternative that closes the port site with a Vector X Closure that approximates the tissue resulting in 75% less tension. There are no other devices on the market today that approximates tissue to close a port site. All competing products use a closed loop suture, which places a higher level of tension on tissue.